Manager, IT and Cybersecurity

Requirements

• At least 6 years of experience in IT operations, including hands‑on leadership in a growing organization
• Minimum of 3 years of experience in the biotechnology or pharmaceutical industry
• Strong expertise in Microsoft technologies, M365, and PC environments
• Solid understanding of cybersecurity principles, data privacy standards, and compliance frameworks
• Experience managing IT projects and implementing infrastructure across diverse technologies
• Proficiency in systems administration, networking, security tools, databases, storage systems, and communication technologies
• Demonstrated ability to optimize support systems and workflows including use of responsible AI capabilities
• Strong critical thinking, decision‑making, and prioritization skills
• Service‑oriented mindset with excellent interpersonal, verbal, and written communication abilities

Additional Information

The Manager, IT & Cybersecurity will lead day-to-day corporate IT operations and cybersecurity execution, ensuring reliable, secure, and scalable technology services for the business. Reporting to the CFO this role manages operational priorities, drives continuous improvement, and partners across functions to align technology support with organizational needs. This individual will work closely with the Managed Service Provider (MSP), oversee end‑user computing tools including M365, laptops, AV systems, and security infrastructure, and serve as a trusted partner to teams across Lexeo. The ideal candidate thrives in a fast‑paced, growing biotechnology environment and is equally comfortable troubleshooting immediate issues and implementing process improvements, including the responsible use of AI to optimize ticket triage/knowledge management and accelerate issue resolution, that support future growth. About Lexeo Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich's Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact. Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home. Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at lexeotx? Share your experience